Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

The Nasdaq Now: Fresh Woes for Peregrine Pharmaceuticals (NASDAQ:PPHM)


Royale Energy and StemCells are among gainers of the day.

MINYANVILLE ORIGINAL Better-than-expected jobs data and hopes for new stimulatory measures from the Chinese government pushed US stocks up a slight notch.

The Nasdaq Composite (INDEXNASDAQ:.IXIC) is up 0.88% to 3,120.85 points on below-average volume of 677.62 million as of 12:02 p.m. EDT.

Royale Energy (NASDAQ:ROYL) was among the top gainers, up 43.08% to $4.65, as the energy company confirmed an Alaska acreage development plan.

StemCells Inc. (NASDAQ:STEM) also jumped 6.74% to $2.06 after the company reported the first successful transplant of neural stem cells into a patient with an incomplete injury.

After three days of losses, Apple (NASDAQ:AAPL) was on the rise again in intraday trading. It gained 1.64% to $676.10.

Among losers, the troubles for Peregrine Pharmaceuticals (NASDAQ:PPHM) continued. After a 78% plunge on Monday, shares of Peregrine were down 35.54% to $1.07 after a SEC filing revealed that the company defaulted on a $30 million loan agreement it entered into on August 30.

Life Partners Holdings (NASDAQ:LPHI) gave back some of yesterday's gains. It dipped 6.83% to $3.41.

Twitter: @sterlingwong
No positions in stocks mentioned.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.

Copyright 2011 Minyanville Media, Inc. All Rights Reserved.
Featured Videos